Apigenin alleviates oxidative stress-induced myocardial injury by regulating SIRT1 signaling pathway
Kun Xu,Yao Yang,Ming Lan,Jiannan Wang,Bing Liu,Mingjing Yan,Hua Wang,Wenlin Li,Shenghui Sun,Kaiyi Zhu,Xiyue Zhang,Mingyan Hei,Xiuqing Huang,Lin Dou,Weiqing Tang,Qing He,Jian Li,Tao Shen
DOI: https://doi.org/10.1016/j.ejphar.2023.175584
IF: 5.195
2023-02-13
European Journal of Pharmacology
Abstract:Apigenin is a natural flavonoid which is widely found in vegetables and fruits. However, the mechanism of apigenin in oxidative stress-induced myocardial injury has not been fully elucidated. We established an isoproterenol (Iso)-induced myocardial injury mouse model and a hypoxia/reoxygenation (H/R)-induced H9c2 cell injury model, followed by pretreatment with apigenin to explore its protective effects. Apigenin can significantly alleviate isoproterenol-induced oxidative stress, cell apoptosis and myocardial remodeling in vivo. Apigenin pretreatment can also significantly improve cardiomyocyte morphology, decrease H/R induced oxidative stress, and attenuate cell apoptosis and inflammation in vitro. Further mechanism study revealed that apigenin treatment reversed isoprenaline and H/R-induced decrease of Sirtuin1 (SIRT1). Molecular docking results proved that apigenin can form hydrogen bond with 230 Glu, a key site of SIRT1 activation, indicating that apigenin is an agonist of SIRT1. Moreover, SIRT1 knockdown by siRNA significantly reversed the protective effect of apigenin in H/R-induced myocardial injury. In conclusion, apigenin protects cardiomyocyte function from oxidative stress-induced myocardial injury by modulating SIRT1 signaling pathway, which provides a new potential therapeutic natural compound for the clinical treatment of cardiovascular diseases.
pharmacology & pharmacy
What problem does this paper attempt to address?